• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 3. An amplified fluorescence detection of T4 polynucleotide kinase activity based on coupled exonuclease III reaction and a graphene oxide platform?
  Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
• 4. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 5. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Hydroxy fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Hydroxy fatty acids

3-Hydroxy Valproic Acid (Mixture of Diastereomers)

The compound with CAS No. 58888-84-9, commonly referred to as 3-Hydroxy Valproic Acid (Mixture of Diastereomers), is a significant molecule in the field of organic chemistry and pharmacology. This compound is a derivative of valproic acid, which is well-known for its role in the treatment of epilepsy and bipolar disorder. The addition of a hydroxyl group at the third carbon position introduces unique chemical and biological properties, making it an interesting subject for research and development.

3-Hydroxy Valproic Acid exists as a mixture of diastereomers, which are stereoisomers that are not mirror images of each other. The presence of multiple stereocenters in the molecule contributes to its complexity and diversity in terms of physical and chemical properties. This stereochemical variation is crucial in determining the compound's activity and selectivity in biological systems. Recent studies have highlighted the importance of stereochemistry in drug design, emphasizing the need for precise control over the stereochemical composition of such compounds.

The synthesis of 3-Hydroxy Valproic Acid involves a series of carefully designed reactions, often utilizing advanced techniques such as asymmetric catalysis or enzymatic methods to achieve high enantioselectivity. Researchers have explored various routes to optimize the yield and purity of the compound, particularly focusing on scalable methods suitable for industrial production. These advancements have significantly contributed to the feasibility of using this compound in preclinical and clinical studies.

One of the most promising applications of 3-Hydroxy Valproic Acid lies in its potential as a precursor for more complex molecules with therapeutic potential. By modifying its structure, scientists can generate derivatives that target specific biological pathways or receptors. For instance, recent research has demonstrated that certain derivatives exhibit enhanced activity against neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. These findings underscore the versatility of 3-Hydroxy Valproic Acid as a starting material for drug discovery.

In addition to its role in drug development, 3-Hydroxy Valproic Acid has shown potential in other areas such as agrochemicals and materials science. Its ability to interact with various biological systems makes it a valuable tool for understanding fundamental biochemical processes. Moreover, the compound's stability under different conditions has been extensively studied, providing insights into its suitability for diverse applications.

Recent advancements in analytical techniques have enabled researchers to gain deeper insights into the structural and functional properties of 3-Hydroxy Valproic Acid. Techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography have been instrumental in characterizing the compound's stereochemistry and conformational dynamics. These studies have not only improved our understanding of the molecule but also paved the way for more precise synthesis and application strategies.

Furthermore, computational modeling has played a pivotal role in predicting the behavior of 3-Hydroxy Valproic Acid in different environments. By employing molecular docking and dynamics simulations, researchers can anticipate how this compound interacts with target proteins or enzymes. Such computational approaches have significantly accelerated the drug discovery process by reducing the need for extensive experimental trials.

In conclusion, 3-Hydroxy Valproic Acid (Mixture of Diastereomers) is a versatile and intriguing compound with wide-ranging applications across various scientific disciplines. Its unique chemical properties, coupled with advancements in synthesis and characterization techniques, position it as a valuable asset in both academic research and industrial development. As ongoing studies continue to unravel its full potential, this compound is poised to make significant contributions to fields such as medicine, agriculture, and materials science.

• 473-86-9(3-Hydroxy-2-methylbutanoic Acid)
• 668485-40-3((2R)-2-(hydroxymethyl)hexanoic acid)
• 17502-28-2(rac-(1R,2S)-2-hydroxycyclopentane-1-carboxylic acid, cis)
• 40309-49-7(3-hydroxy-5-methylhexanoic acid)
• 512-16-3(2-(1-hydroxycyclohexyl)butanoic acid)
• 5980-21-2(3-Hydroxy-4-methylpentanoic Acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)